Kintara Therapeutics, Inc. (KTRA) Financials

NASDAQ Currency in USD Disclaimer

$2.48

Last update: 01:00 PM EST
Day's range
$2.15
Day's range
$2.74
$0$0-$10M-$10M-$20M-$20M-$30M-$30M-$40M-$40MEarning201820182019201920202020202120212022202220232023202420244%4%3%3%2%2%1%1%0%0%Profit Margin
Profit Margin
Revenue
Earnings

KTRA Income statement / Annual

Last year (2024), Kintara Therapeutics, Inc.'s total revenue was $0.00, and the percentage change from the previous year is not available. In 2024, Kintara Therapeutics, Inc.'s net income was -$8.50 M. See Kintara Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 06/30/2024 06/30/2023 06/30/2022 06/30/2021 06/30/2020 06/30/2019 06/30/2018 06/30/2017 06/30/2016 06/30/2015
Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Cost of Revenue $55.00 K $60.00 K $60.00 K $32.00 K $10.00 K $16.35 K $24.53 K $16.68 K $10.29 K $0.00
Gross Profit -$55.00 K -$60.00 K -$60.00 K -$32.00 K -$10.00 K -$16.35 K -$24.53 K -$16.68 K -$10.29 K $0.00
Gross Profit Ratio 0 0 0 0 0 0 0 0 0 0
Research and Development Expenses $2.66 M $9.31 M $15.17 M $11.82 M $3.63 M $3.66 M $7.13 M $5.00 M $3.36 M $2.56 M
General & Administrative Expenses $5.79 M $5.49 M $7.51 M $9.76 M $4.51 M $4.74 M $4.04 M $3.32 M $2.85 M $2.17 M
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $5.79 M $5.49 M $7.51 M $9.76 M $4.51 M $4.74 M $4.04 M $3.32 M $2.85 M $2.17 M
Other Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expenses $8.45 M $14.80 M $22.68 M $21.57 M $8.14 M $8.40 M $11.17 M $8.32 M $6.21 M $4.72 M
Cost And Expenses $8.45 M $14.80 M $22.68 M $21.57 M $8.14 M $8.40 M $11.17 M $8.32 M $6.21 M $4.72 M
Interest Income $0.00 $137.00 K $14.00 K $120.00 $75.25 K $60.70 K $33.24 K $457.00 $108.00 $363.00
Interest Expense $0.00 $0.00 $14.00 K $26.00 K $0.00 $0.00 $0.00 $0.00 $0.00 $2.09 K
Depreciation & Amortization $55.00 K $60.00 K $60.00 K $32.00 K $10.00 K $16.35 K $24.53 K $16.68 K $10.29 K $363.00
EBITDA -$8.40 M -$14.74 M -$22.62 M -$38.15 M -$9.12 M -$8.03 M -$11.11 M -$8.07 M -$8.85 M -$4.72 M
EBITDA Ratio 0 0 0 0 0 0 0 0 0 0
Operating Income Ratio 0 0 0 0 0 0 0 0 0 0
Total Other Income/Expenses Net $131.00 K $147.00 K $21.00 K -$16.63 M -$982.00 K $350.28 K $36.35 K $324.16 K -$2.27 M $376.89 K
Income Before Tax -$8.32 M -$14.65 M -$22.66 M -$38.30 M -$9.13 M -$8.05 M -$11.14 M -$8.08 M -$8.86 M -$4.80 M
Income Before Tax Ratio 0 0 0 0 0 0 0 0 0 0
Income Tax Expense $76.00 K -$147.00 K -$42.00 K $26.00 K $981.37 K -$639.85 K -$39.46 K -$477.67 K $5.30 M $69.29 K
Net Income -$8.50 M -$14.65 M -$22.66 M -$38.32 M -$10.11 M -$7.41 M -$11.14 M -$8.08 M -$8.86 M -$4.80 M
Net Income Ratio 0 0 0 0 0 0 0 0 0 0
EPS -3.23 -9.27 -25.8 -74.02 -48.39 -143.87 -266.96 -335.43 -404.86 -251.98
EPS Diluted -3.23 -9.27 -25.8 -74.02 -48.39 -143.87 -266.96 -335.43 -404.86 -251.98
Weighted Average Shares Out $2.64 M $1.62 M $974.04 K $517.72 K $208.88 K $51.49 K $41.72 K $24.09 K $21.90 K $19.03 K
Weighted Average Shares Out Diluted $26.35 M $1.62 M $974.00 K $517.72 K $208.88 K $51.49 K $41.72 K $24.09 K $21.90 K $19.03 K
Link